ArticleBMC women's health2026
Prevalence, antimicrobial resistance, and associated factors of bacterial vaginosis and aerobic vaginitis among women suspected of STIs in Bahir Dar, Ethiopia.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBacterial vaginosis (BV) and aerobic vaginitis (AV) are characterized by an imbalance of vaginal microbiome, becomes a serious public health crisis especially in low and middle income country.
objectiveTo determine the Prevalence, Antimicrobial Resistance (AMR), and Associated Factors of Bacterial Vaginosis and Aerobic Vaginitis among Women Suspected of sexually transmitted infections (STIs) in Bahir Dar, Ethiopia. MATERIALS AND
methodsA facility-based cross-sectional study was conducted among 261 women suspected of STIs at selected health institutions in Bahir Dar City, northwest Ethiopia (February–May 2025). All eligible women were invited to minimize selection bias and ensure broad representation. Data was collected through structured interview, vaginal swab samples were collected and used for Gram stain methods to evaluate BV and AV scores according to the Nugent’s and Donder’s criteria, respectively. In situation of AV cases the aerobic bacterial pathogens and their antibiotic resistance were determined using the Kirby-Bauer disk diffusion method according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Logistic regression was used to assess associations, with results reported as odds ratios (ORs) and 95% confidence intervals (CIs). Variables with a p-value less than 0.05 were considered statistically significant.
resultsThe overall prevalence of bacterial vaginosis (BV) was 20.7% (54/261), while aerobic vaginitis (AV) was 17.2% (45/261), with a dual infection rate of 2.7% (7/261). Among 45 aerobic bacterial isolates, 25 (55.6%) were Gram-positive and 20 (44.4%) were Gram-negative. The most common species were Staphylococcus aureus (13/45, 28.9%) and Escherichia coli (12/45, 26.7%). Gram-positive species showed variable resistance, with 20% classified as MDR. All E. coli and K. pneumoniae isolates were MDR, while P. aeruginosa showed partial resistance; overall MDR prevalence was 49%. The most important factors significantly associated with BV were single marital status, occupation (commercial sex worker, housewife), vaginal pH > 4.5, Donders’ score (moderate to severe), and history of STI or abortion. For AV, key factors included occupation (housewife, commercial sex worker), vaginal burning sensation, vaginal pH > 4.5, positive BV status, and Nugent score indicating BV.
conclusionBacterial vaginosis and aerobic vaginitis were prevalent among STI-suspected women in Bahir Dar, Ethiopia, with substantial multidrug resistance and significant associations with selected socio-demographic and clinical factors, underscoring the need for improved screening and resistance-guided management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.